These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11513907)

  • 61. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy].
    Shigeto E; Murakami I; Yokosaki Y
    Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
    Park SK; Kim CT; Song SD
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tuberculosis, Russia, and the Holy Grail.
    Banatvala N; Peremitin GG
    Lancet; 1999 Mar; 353(9157):999-1000. PubMed ID: 10459925
    [No Abstract]   [Full Text] [Related]  

  • 64. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes.
    Mor Z; Goldblatt D; Kaidar-Shwartz H; Cedar N; Rorman E; Chemtob D
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1195-201. PubMed ID: 25216833
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The comparison of tuberculosis treatments: a short course therapy and the directly observed short course treatment (DOTS), East Java Province, Indonesia.
    Roosihermiatie B; Nishiyama M; Nakae K
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):85-8. PubMed ID: 11023071
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of administering short-course, standardized regimens in individuals infected with drug-resistant Mycobacterium tuberculosis strains.
    Furin JJ; Becerra MC; Shin SS; Kim JY; Bayona J; Farmer PE
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):132-6. PubMed ID: 10746502
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment outcome of pulmonary tuberculosis in eastern Taiwan - experience at a medical center.
    Lee JJ; Wu RL; Lee YS; Wu YC; Chiang CY
    J Formos Med Assoc; 2007 Jan; 106(1):25-30. PubMed ID: 17282967
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study.
    Soeroto AY; Pratiwi C; Santoso P; Lestari BW
    PLoS One; 2021; 16(2):e0246284. PubMed ID: 33556094
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis.
    Zwarenstein M; Schoeman JH; Vundule C; Lombard CJ; Tatley M
    Lancet; 1998 Oct; 352(9137):1340-3. PubMed ID: 9802271
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Chest radiograph in assessing the results of treatment with 6-month short-course chemotherapy of pulmonary tuberculosis].
    Su J; Tu D; Liu J
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Jun; 18(3):173-4, 191-2. PubMed ID: 8565089
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [TUBERCULOSIS EPIDEMIOLOGICAL PARAMETERS IN CHILDREN IN SOME AREAS OF THE NORTH-WESTERN FEDERAL DISTRICT].
    Tuberk Biolezni Legkih; 2010; (1):7-9. PubMed ID: 27529923
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug-resistant tuberculosis: desperate measures?
    Cullinan T
    Lancet; 2001 Apr; 357(9262):1124. PubMed ID: 11297986
    [No Abstract]   [Full Text] [Related]  

  • 73. Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective.
    Ditah IC; Reacher M; Palmer C; Watson JM; Innes J; Kruijshaar ME; Luma HN; Abubakar I
    Thorax; 2008 May; 63(5):440-6. PubMed ID: 17615085
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Control of tuberculosis in Russia.
    Coker R
    Lancet; 2001 Aug; 358(9280):434-5. PubMed ID: 11513902
    [No Abstract]   [Full Text] [Related]  

  • 75. Current management of respiratory tuberculosis.
    Ormerod P
    Br J Hosp Med; 1987 Apr; 37(4):304-8. PubMed ID: 3580684
    [TBL] [Abstract][Full Text] [Related]  

  • 76. DOTS and DOTS-plus: not the only answer.
    Farmer P
    Ann N Y Acad Sci; 2001 Dec; 953():165-84. PubMed ID: 11795410
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis.
    Kendall EA; Fojo AT; Dowdy DW
    Lancet Respir Med; 2017 Mar; 5(3):191-199. PubMed ID: 27989591
    [TBL] [Abstract][Full Text] [Related]  

  • 78. From the Centers for Disease Control and Prevention. Tuberculosis treatment interruptions--Ivanovo Oblast, Russian Federation, 1999.
    JAMA; 2001 Apr; 285(15):1953-4. PubMed ID: 11336045
    [No Abstract]   [Full Text] [Related]  

  • 79. Short-course chemotherapy of pulmonary tuberculosis.
    Geiter LJ; O'Brien RJ
    Am Rev Respir Dis; 1987 May; 135(5):1215. PubMed ID: 3555197
    [No Abstract]   [Full Text] [Related]  

  • 80. A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis.
    Imperial MZ; Nahid P; Phillips PPJ; Davies GR; Fielding K; Hanna D; Hermann D; Wallis RS; Johnson JL; Lienhardt C; Savic RM
    Nat Med; 2018 Nov; 24(11):1708-1715. PubMed ID: 30397355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.